These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16566896

  • 21. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype.
    Watanabe T, Sudoh M, Miyagishi M, Akashi H, Arai M, Inoue K, Taira K, Yoshiba M, Kohara M.
    Gene Ther; 2006 Jun; 13(11):883-92. PubMed ID: 16496015
    [Abstract] [Full Text] [Related]

  • 22. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
    Ariumi Y, Kuroki M, Abe K, Dansako H, Ikeda M, Wakita T, Kato N.
    J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
    [Abstract] [Full Text] [Related]

  • 23. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Trujillo-Murillo K, Rincón-Sánchez AR, Martínez-Rodríguez H, Bosques-Padilla F, Ramos-Jiménez J, Barrera-Saldaña HA, Rojkind M, Rivas-Estilla AM.
    Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.
    Vlassov AV, Korba B, Farrar K, Mukerjee S, Seyhan AA, Ilves H, Kaspar RL, Leake D, Kazakov SA, Johnston BH.
    Oligonucleotides; 2007 May; 17(2):223-36. PubMed ID: 17638526
    [Abstract] [Full Text] [Related]

  • 26. Regulation of the hepatitis C virus genome replication by miR-199a.
    Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K.
    J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
    [Abstract] [Full Text] [Related]

  • 27. [Construction and functional characterization of a monocistronic replicon based on the HCV genotype 2a promotor].
    Li XL, Lei Y, Zhong S, Peng FY, Zhou Z, Li K, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):103-7. PubMed ID: 22464780
    [Abstract] [Full Text] [Related]

  • 28. Interference of hepatitis C virus RNA replication by short interfering RNAs.
    Kapadia SB, Brideau-Andersen A, Chisari FV.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):2014-8. PubMed ID: 12566571
    [Abstract] [Full Text] [Related]

  • 29. Interferon regulatory factor 3-independent double-stranded RNA-induced inhibition of hepatitis C virus replicons in human embryonic kidney 293 cells.
    Ali S, Kukolj G.
    J Virol; 2005 Mar 18; 79(5):3174-8. PubMed ID: 15709037
    [Abstract] [Full Text] [Related]

  • 30. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.
    Kanda T, Steele R, Ray R, Ray RB.
    J Virol; 2007 Jan 18; 81(2):669-76. PubMed ID: 17079316
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line.
    Ali S, Pellerin C, Lamarre D, Kukolj G.
    J Virol; 2004 Jan 18; 78(1):491-501. PubMed ID: 14671129
    [Abstract] [Full Text] [Related]

  • 32. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
    Ng TI, Mo H, Pilot-Matias T, He Y, Koev G, Krishnan P, Mondal R, Pithawalla R, He W, Dekhtyar T, Packer J, Schurdak M, Molla A.
    Hepatology; 2007 Jun 18; 45(6):1413-21. PubMed ID: 17518369
    [Abstract] [Full Text] [Related]

  • 33. RNA interference from multimeric shRNAs generated by rolling circle transcription.
    Seyhan AA, Vlassov AV, Johnston BH.
    Oligonucleotides; 2006 Jun 18; 16(4):353-63. PubMed ID: 17155910
    [Abstract] [Full Text] [Related]

  • 34. Suppression of hepatitis C virus genome replication in cells with RNA-cleaving DNA enzymes and short-hairpin RNA.
    Lee B, Kim KB, Oh S, Choi JS, Park JS, Min DH, Kim DE.
    Oligonucleotides; 2010 Dec 18; 20(6):285-96. PubMed ID: 20863235
    [Abstract] [Full Text] [Related]

  • 35. Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES).
    Torrecilla J, Del Pozo-Rodríguez A, Solinís MÁ, Apaolaza PS, Berzal-Herranz B, Romero-López C, Berzal-Herranz A, Rodríguez-Gascón A.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():808-17. PubMed ID: 27451369
    [Abstract] [Full Text] [Related]

  • 36. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs.
    Randall G, Grakoui A, Rice CM.
    Proc Natl Acad Sci U S A; 2003 Jan 07; 100(1):235-40. PubMed ID: 12518066
    [Abstract] [Full Text] [Related]

  • 37. Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
    Kim SJ, Kim JH, Sun JM, Kim MG, Oh JW.
    J Viral Hepat; 2009 Oct 07; 16(10):697-704. PubMed ID: 19243496
    [Abstract] [Full Text] [Related]

  • 38. Subgenomic replicon derived from a cell line infected with the hepatitis C virus.
    Kishine H, Sugiyama K, Hijikata M, Kato N, Takahashi H, Noshi T, Nio Y, Hosaka M, Miyanari Y, Shimotohno K.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):993-9. PubMed ID: 12051758
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of hcv replication in HCV replicon by shRNAs.
    Hamazaki H, Takahashi H, Shimotohno K, Miyano-Kurosaki N, Takaku H.
    Nucleosides Nucleotides Nucleic Acids; 2006 May 10; 25(7):801-5. PubMed ID: 16898418
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs.
    Chevalier C, Saulnier A, Benureau Y, Fléchet D, Delgrange D, Colbère-Garapin F, Wychowski C, Martin A.
    Mol Ther; 2007 Aug 10; 15(8):1452-62. PubMed ID: 17505476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.